The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies

Frontiers in Pharmacology

Volumn 5 JUL, Issue , 2014, Pages

  Xu, Jun ^a   Liu, Xiao ^a   Koyama, Yukinori ^a   Wang, Ping ^a   Lan, Tian ^a   Kim, In Gyu ^a   Kim H , In ^a   Ma, Hsiao Yen ^a   Kisseleva, Tatiana ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Carbon tetrachloride; Fibrocyte; Hepatic stellate cells; Liver fibrosis; Myofibroblasts; Portal fibroblast

Indexed keywords

COLLAGEN;

BONE MARROW CELL; CELL ACTIVATION; CELL FATE; CELL FUNCTION; CELL MIGRATION; CELL POPULATION; DISEASE ASSOCIATION; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; GENETIC REGULATION; HUMAN; LIVER FIBROSIS; MYOFIBROBLAST; NONHUMAN; PATHOGENESIS; PHENOTYPE; PROTEIN SYNTHESIS; REVIEW; STELLATE CELL; TRANSGENIC MOUSE;

EID: 84904736948     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2014.00167     Document Type: Review

References (169)

1. Abe, R., Donnelly, S. C., Peng, T., Bucala, R., and Metz, C. N. (2001). Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J. Immunol. 166, 7556-7562. doi: 10.4049/jimmunol.166.12.7556
2. Asahina, K., Sato, H., Yamasaki, C., Kataoka, M., Shiokawa, M., Katayama, S.,et al. (2002). Pleiotrophin/heparin-binding growth-associated molecule as a mitogen of rat hepatocytes and its role in regeneration and development of liver. Am. J. Pathol. 160, 2191-2205. doi: 10.1016/S0002-9440(10)61167-4
3. Asahina, K., Tsai, S. Y., Li, P., Ishii, M., Maxson, R. E. Jr., Sucov, H. M.,et al. (2009). Mesenchymal origin of hepatic stellate cells, submesothelial cells, and perivascular mesenchymal cells during mouse liver development. Hepatology 49, 998-1011. doi: 10.1002/hep.22721
4. Asahina, K., Zhou, B., Pu, W. T., and Tsukamoto, H. (2011). Septum transversum-derived mesothelium gives rise to hepatic stellate cells and perivascular mesenchymal cells in developing mouse liver. Hepatology 53, 983-995. doi: 10.1002/hep.24119
5. Baghdasaryan, A., Claudel, T., Kosters, A., Gumhold, J., Silbert, D., Thuringer, A.,et al. (2010). Curcumin improves sclerosing cholangitis in Mdr2-/- mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation. Gut 59, 521-530. doi: 10.1136/gut.2009.186528
6. Balmelli, C., Alves, M. P., Steiner, E., Zingg, D., Peduto, N., Ruggli, N.,et al. (2007). Responsiveness of fibrocytes to toll-like receptor danger signals. Immunobiology 212, 693-699. doi: 10.1016/j.imbio.2007.09.009
7. Balmelli, C., Ruggli, N., McCullough, K., and Summerfield, A. (2005). Fibrocytes are potent stimulators of anti-virus cytotoxic T cells. J. Leukoc. Biol. 77, 923-933. doi: 10.1189/jlb.1204701
8. Bataller, R., and Brenner, D. A. (2005). Liver fibrosis. J. Clin. Invest. 115, 209-218. doi: 10.1172/JCI24282
9. Bataller, R., Schwabe, R. F., Choi, Y. H., Yang, L., Paik, Y. H., Lindquist, J.,et al. (2003). NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J. Clin. Invest. 112, 1383-1394. doi: 10.1172/JCI18212
10. Bellini, A., and Mattoli, S. (2007). The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. Lab. Invest. 87, 858-870. doi: 10.1038/labinvest.3700654
11. Berg, T., Rountree, C. B., Lee, L., Estrada, J., Sala, F. G., Choe, A.,et al. (2007). Fibroblast growth factor 10 is critical for liver growth during embryogenesis and controls hepatoblast survival via beta-catenin activation. Hepatology 46, 1187-1197. doi: 10.1002/hep.21814
12. Bethanis, S. K., and Theocharis, S. E. (2006). Leptin in the field of hepatic fibrosis: a pivotal or an incidental player? Dig. Dis. Sci. 51, 1685-1696. doi: 10.1007/s10620-006-9126-0
13. Bhunchet, E., and Wake, K. (1992). Role of mesenchymal cell populations in porcine serum-induced rat liver fibrosis. Hepatology 16, 1452-1473. doi: 10.1002/hep.1840160623
14. Bosselut, N., Housset, C., Marcelo, P., Rey, C., Burmester, T., Vinh, J.,et al. (2010). Distinct proteomic features of two fibrogenic liver cell populations: hepatic stellate cells and portal myofibroblasts. Proteomics 10, 1017-1028.
15. Brenner, D. A., and Kisseleva, T. (2011). "Contribution of fibrocytes to liver fibrosis: current concept and future prospectives," in Fibrocytes in Health and Disease, ed. R. Bucala (Singapore: World Scientific Press), bl228.
16. Brenner, D. A., Kisseleva, T., Scholten, D., Paik, Y. H., Iwaisako, K., Inokuchi, S.,et al. (2012). Origin of myofibroblasts in liver fibrosis. Fibrogenesis Tissue Repair 5(Suppl. 1):S17. doi: 10.1186/1755-1536-5-S1-S17
17. Brenner, D. A., Rippe, R. A., and Veloz, L. (1989). Analysis of the collagen alpha 1(I). promoter. Nucleic Acids Res. 17, 6055-6064. doi: 10.1093/nar/17.15.6055
18. Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D. S.,et al. (2004). Neutrophil extracellular traps kill bacteria. Science 303, 1532-1535. doi: 10.1126/science.1092385
19. Brinkmann, V., and Zychlinsky, A. (2007). Beneficial suicide: why neutrophils die to make NETs. Nat. Rev. Microbiol. 5, 577-582. doi: 10.1038/nrmicro1710
20. Bucala, R. (2008). Circulating fibrocytes: cellular basis for NSF. J. Am. Coll. Radiol. 5, 36-39. doi: 10.1016/j.jacr.2007.08.016
21. Bucala, R., Spiegel, L. A., Chesney, J., Hogan, M., and Cerami, A. (1994). Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med. 1, 71-81.
22. Cassiman, D., Barlow, A., Vander Borght, S., Libbrecht, L., and Pachnis, V. (2006). Hepatic stellate cells do not derive from the neural crest. J. Hepatol. 44, 1098-1104. doi: 10.1016/j.jhep.2005.09.023
23. Cassiman, D., Libbrecht, L., Desmet, V., Denef, C., and Roskams, T. (2002). Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. J. Hepatol. 36, 200-209. doi: 10.1016/S0168-8278(01)00260-4
24. Chapman, G. B., and Eagles, D. A. (2007). Ultrastructural features of Glisson's capsule and the overlying mesothelium in rat, monkey and pike liver. Tissue Cell 39, 343-351. doi: 10.1016/j.tice.2007.06.005
25. Chesney, J., Bacher, M., Bender, A., and Bucala, R. (1997). The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc. Natl. Acad. Sci. U.S.A. 94, 6307-12. doi: 10.1073/pnas.94.12.6307
26. Choi, S. S., and Diehl, A. M. (2009). Epithelial-to-mesenchymal transitions in the liver. Hepatology 50, 2007-2013. doi: 10.1002/hep.23196
27. Chow, O. A., von Köckritz-Blickwede, M., Bright, A. T., Hensler, M. E., Zinkernagel, A. S., Cogen, A. L.,et al., (2010). Statins enhance formation of phagocyte extracellular traps. Cell Host Microbe 8, 445-454. doi: 10.1016/j.chom.2010.10.005
28. Chu, A. S., Diaz, R., Hui, J. J., Yanger, K., Zong, Y., Alpini, G.,et al. (2011). Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis. Hepatology 53, 1685-1695. doi: 10.1002/hep.24206
29. Clouzeau-Girard, H., Guyot, C., Combe, C., Moronvalle-Halley, V., Housset, C., Lamireau, T.,et al. (2006). Effects of bile acids on biliary epithelial cell proliferation and portal fibroblast activation using rat liver slices. Lab. Invest. 86, 275-285. doi: 10.1038/labinvest.3700386
30. Cowper, S. E., and Bucala, R. (2003). Nephrogenic fibrosing dermopathy: suspect identified, motive unclear. Am. J. Dermatopathol. 25, 358. doi: 10.1097/00000372-200308000-00017
31. Curnow, S. J., Fairclough, M., Schmutz, C., Kissane, S., Denniston, A. K., Nash, K.,et al. (2010). Distinct types of fibrocyte can differentiate from mononuclear cells in the presence and absence of serum. PLoS ONE 5:e9730. doi: 10.1371/journal.pone.0009730
32. De Minicis, S., Seki, E., Uchinami, H., Kluwe, J., Zhang, Y., Brenner, D. A.,et al. (2007). Gene expression profiles during hepatic stellate cell activation in culture and in vivo. Gastroenterology 132, 1937-1946. doi: 10.1053/j.gastro.2007.02.033
33. Deng, Y. H., Pu, C. L., Li, Y. C., Zhu, J., Xiang, C., Zhang, M. M.,et al. (2011). Analysis of biliary epithelial-mesenchymal transition in portal tract fibrogenesis in biliary atresia. Dig. Dis. Sci. 56, 731-140. doi: 10.1007/s10620-010-1347-6
34. Desmouliere, A., Darby, I., Costa, A. M., Raccurt, M., Tuchweber, B., Sommer, P.,et al. (1997). Extracellular matrix deposition, lysyl oxidase expression, and myofibroblastic differentiation during the initial stages of cholestatic fibrosis in the rat. Lab. Invest. 76, 765-778.
35. Dranoff, J. A., and Wells, R. G. (2010). Portal fibroblasts: underappreciated mediators of biliary fibrosis. Hepatology 51, 1438-1444. doi: 10.1002/hep.23405
36. Dranoff, J. A., Kruglov, E. A., Robson, S. C., Braun, N., Zimmermann, H., Sévigny, J.,et al. (2002). The ecto-nucleoside triphosphate diphosphohydrolase NTPDase2/CD39L1 is expressed in a novel functional compartment within the liver. Hepatology 36, 1135-1144. doi: 10.1053/jhep.2002.36823
37. Dudas, J., Mansuroglu, T., Batusic, D., Saile, B., and Ramadori, G. (2007). Thy-1 is an in vivo and in vitro marker of liver myofibroblasts. Cell Tissue Res. 329, 503-514. doi: 10.1007/s00441-007-0437-z
38. Ekert, J. E., Murray, L. A., Das, A. M., Sheng, H., Giles-Komar, J., and Rycyzyn, M. A. (2011). Chemokine (C-C motif). ligand 2 mediates direct and indirect fibrotic responses in human and murine cultured fibrocytes. Fibrogenesis Tissue Repair 4 23. doi: 10.1186/1755-1536-4-23
39. Enzan, H., Himeno, H., Iwamura, S., Onishi, S., Saibara, T., Yamamoto, Y.,et al. (1994). Alpha-smooth muscle actin-positive perisinusoidal stromal cells in human hepatocellular carcinoma. Hepatology 19, 895-903.
40. Eyden, B. (2008). The myofibroblast: phenotypic characterization as a prerequisite to understanding its functions in translational medicine. J. Cell. Mol. Med. 12, 22-37. doi: 10.1111/j.1582-4934.2007.00213.x
41. Fabris, L., and Strazzabosco, M. (2011). Epithelial-mesenchymal interactions in biliary diseases. Semin. Liver Dis. 31, 11-32. doi: 10.1055/s-0031-1272832
42. Fallowfield, J. A., Mizuno, M., Kendall, T. J., Constandinou, C. M., Benyon, R. C., Duffield, J. S.,et al. (2007). Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. J. Immunol. 178, 5288-5295. doi: 10.4049/jimmunol.178.8.5288
43. Fausther, M., and Dranoff, J. A. (2011). New insights on the pathogenesis of biliary cirrhosis provided by studies in FXR knockout mice. J. Hepatol. 55, 939-940. doi: 10.1016/j.jhep.2011.04.013
44. Fausther, M., Lavoie, E. G., and Dranoff, J. A. (2013). Contribution of myofibroblasts of different origins to liver fibrosis. Curr. Pathobiol. Rep. 1, 225-230. doi: 10.1007/s40139-013-0020-0
45. Fausther, M., Sheung, N., Saiman, Y., Bansal, M. B., and Dranoff, J. A. (2012). Activated hepatic stellate cells upregulate transcription of ecto-5'-nucleotidase/CD73 via specific SP1 and SMAD promoter elements. Am. J. Physiol. Gastrointest. Liver Physiol. 303, G904-G914. doi: 10.1152/ajpgi.00015.2012
46. Fichtner-Feigl, S., Strober, W., Kawakami, K., Puri, R. K., and Kitani, A. (2006). IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nat. Med. 12, 99-106. doi: 10.1038/nm1332
47. Fickert, P., Fuchsbichler, A., Moustafa, T., Wagner, M., Zollner, G., Halilbasic, E.,et al. (2009). Farnesoid X receptor critically determines the fibrotic response in mice but is expressed to a low extent in human hepatic stellate cells and periductal myofibroblasts. Am. J. Pathol. 175, 2392-23405. doi: 10.2353/ajpath.2009.090114
48. Forbes, S. J., and Parola, M. (2011). Liver fibrogenic cells. Best Pract. Res. Clin. Gastroenterol. 25, 207-217. doi: 10.1016/j.bpg.2011.02.006
49. Friedman, S. L. (2008a). Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol. Rev. 88, 125-172. doi: 10.1152/physrev.00013.2007
50. Friedman, S. L. (2008b). Mechanisms of hepatic fibrogenesis. Gastroenterology 134, 1655-1669. doi: 10.1053/j.gastro.2008.03.003
51. Friedman, S. L., Roll, F. J., Boyles, J., and Bissell, D. M. (1985). Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. Proc. Natl. Acad. Sci. U.S.A. 82, 681-8685. doi: 10.1073/pnas.82.24.8681
52. Gaca, M. D., Zhou, X., Issa, R., Kiriella, K., Iredale, J. P., and Benyon, R. C. (2003). Basement membrane-like matrix inhibits proliferation and collagen synthesis by activated rat hepatic stellate cells: evidence for matrix-dependent deactivation of stellate cells. Matrix Biol. 22, 229-239. doi: 10.1016/S0945-053X(03)00017-9
53. Galan, A., Cowper, S. E., and Bucala, R. (2006). Nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy). Curr. Opin. Rheumatol. 18, 614-617. doi: 10.1097/01.bor.0000245725.94887.8d
54. Geerts, A. (2001). History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Semin. Liver Dis. 21, 311-335. doi: 10.1055/s-2001-17550
55. Giannelli, G., and Antonaci, S. (2005). Immunological and molecular aspects of liver fibrosis in chronic hepatitis C virus infection. Histol. Histopathol. 20, 939-944.
56. Gilbertson, L. (2003). Cre-lox recombination: cre-ative tools for plant biotechnology. Trends Biotechnol. 21, 550-555. doi: 10.1016/j.tibtech.2003.09.011
57. Goddard, C. J., Smith, A., Hoyland, J. A., Baird, P., McMahon, R. F., Freemont, A. J.,et al. (1998). Localisation and semiquantitative assessment of hepatic procollagen mRNA in primary biliary cirrhosis. Gut 43, 433-440. doi: 10.1136/gut.43.3.433
58. Gomperts, B. N., and Strieter, R. M. (2007). Fibrocytes in lung disease. J. Leukoc. Biol. 82, 449-456. doi: 10.1189/jlb.0906587
59. Goodpaster, T., Legesse-Miller, A., Hameed, M. R., Aisner, S. C., Randolph-Habecker, J., and Coller, H. A. (2008). An immunohistochemical method for identifying fibroblasts in formalin-fixed, paraffin-embedded tissue. J. Histochem. Cytochem. 56, 347-358. doi: 10.1369/jhc.7A7287.2007
60. Grieb, G., Steffens, G., Pallua, N., Bernhagen, J., and Bucala, R. (2011). Circulating fibrocytes-biology and mechanisms in wound healing and scar formation. Int. Rev. Cell Mol. Biol. 291, 1-19. doi: 10.1016/B978-0-12-386035-4.00001-X
61. Hao, C., Xie, Y., Peng, M., Ma, L., Zhou, Y., Zhang, Y.,et al. (2013). Inhibition of connective tissue growth factor suppresses hepatic stellate cell activation in vitro and prevents liver fibrosis in vivo. Clin. Exp. Med. 14, 141-150. doi: 10.1007/s10238-013-0229-6
62. Hazra, S., Xiong, S., Wang, J., Rippe, R. A., Krishna, V., Chatterjee, K.,et al. (2004). Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells. J. Biol. Chem. 279, 11392-11401. doi: 10.1074/jbc.M310284200
63. Heinz, S., and Glass, C. K. (2012). Roles of lineage-determining transcription factors in establishing open chromatin: lessons from high-throughput studies. Curr. Top. Microbiol. Immunol. 356, 1-15. doi: 10.1007/82_2011_142
64. Henikoff, S. (2008). Nucleosome destabilization in the epigenetic regulation of gene expression. Nat. Rev. Genet. 9, 15-26. doi: 10.1038/nrg2206
65. Higashiyama, R., Moro, T., Nakao, S., Mikami, K., Fukumitsu, H., Ueda, Y.,et al. (2009). Negligible contribution of bone marrow-derived cells to collagen production during hepatic fibrogenesis in mice. Gastroenterology 137, 1459-1466.e1. doi: 10.1053/j.gastro.2009.07.006
66. Hong, K. M., Belperio, J. A., Keane, M. P., Burdick, M. D., and Strieter, R. M. (2007). Differentiation of human circulating fibrocytes as mediated by transforming growth factor-beta and peroxisome proliferator-activated receptor gamma. J. Biol. Chem. 282, 22910-22920. doi: 10.1074/jbc.M703597200
67. Inokuchi, S., Tsukamoto, H., Park, E., Liu, Z. X., Brenner, D. A., and Seki, E. (2011). Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice. Alcohol. Clin. Exp. Res. 35, 1509-1518.
68. Iredale, J. P. (2001). Hepatic stellate cell behavior during resolution of liver injury. Semin. Liver Dis. 21, 427-436. doi: 10.1055/s-2001-17557
69. Iredale, J. P., Benyon, R. C., Pickering, J., McCullen, M., Northrop, M., Pawley, S.,et al. (1998). Mechanisms of spontaneous resolution of rat liver fibrosis. hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J. Clin. Invest. 102, 538-549. doi: 10.1172/JCI1018
70. Ishida, Y., Kimura, A., Kondo, T., Hayashi, T., Ueno, M., Takakura, N.,et al. (2007). Essential roles of the CC chemokine ligand 3-CC chemokine receptor 5 axis in bleomycin-induced pulmonary fibrosis through regulation of macrophage and fibrocyte infiltration. Am. J. Pathol. 170, 843-854. doi: 10.2353/ajpath.2007.051213
71. Itoh, N., and Ohta, H. (2013). Pathophysiological roles of FGF signaling in the heart. Front. Physiol. 4:247. doi: 10.3389/fphys.2013.00247
72. Iwaisako, K., Brenner, D. A., and Kisseleva, T. (2012). What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis. J. Gastroenterol. Hepatol. 27(Suppl. 2), 65-68. doi: 10.1111/j.1440-1746.2011.07002.x
73. Jaster, R., Lichte, P., Fitzner, B., Brock, P., Glass, A., Karopka, T.,et al. (2005). Peroxisome proliferator-activated receptor gamma overexpression inhibits pro-fibrogenic activities of immortalised rat pancreatic stellate cells. J. Cell Mol. Med. 9, 670-682. doi: 10.1111/j.1582-4934.2005.tb00497.x
74. Jhandier, M. N., Kruglov, E. A., Lavoie, E. G., Sevigny, J., and Dranoff, J. A. (2005). Portal fibroblasts regulate the proliferation of bile duct epithelia via expression of NTPDase2. J. Biol. Chem. 280, 22986-22992. doi: 10.1074/jbc.M412371200
75. Ji, J., Yu, F., Ji, Q., Li, Z., Wang, K., Zhang, J.,et al. (2012). Comparative proteomic analysis of rat hepatic stellate cell activation: a comprehensive view and suppressed immune response. Hepatology 56, 332-349. doi: 10.1002/hep.25650
76. Jinnin, M., Ihn, H., Asano, Y., Yamane, K., Trojanowska, M., and Tamaki, K. (2006). Upregulation of tenascin-C expression by IL-13 in human dermal fibroblasts via the phosphoinositide 3-kinase/Akt and the protein kinase C signaling pathways. J. Invest. Dermatol. 126, 551-560. doi: 10.1038/sj.jid.5700090
77. Kallis, Y. N., and Forbes, S. J. (2009). The bone marrow and liver fibrosis: friend or foe? Gastroenterology 137, 1218-1221. doi: 10.1053/j.gastro.2009.08.026
78. Kalluri, R. (2009). EMT: when epithelial cells decide to become mesenchymal-like cells. J. Clin. Invest. 119, 1417-1419. doi: 10.1172/JCI39675
79. Kalluri, R., and Neilson, E. G. (2003). Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest. 112, 1776-1784. doi: 10.1172/JCI200320530
80. Kessenbrock, K., Krumbholz, M., Schonermarck, U., Back, W., Gross, W. L., Werb, Z.,et al. (2009). Netting neutrophils in autoimmune small-vessel vasculitis. Nat. Med. 15, 623-625. doi: 10.1038/nm.1959
81. Kisseleva, T., and Brenner, D. A. (2006). Hepatic stellate cells and the reversal of fibrosis. J. Gastroenterol. Hepatol. 21(Suppl. 3), S84-S87. doi: 10.1111/j.1440-1746.2006.04584.x
82. Kisseleva, T., and Brenner, D. A. (2007). Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis. J. Gastroenterol. Hepatol. 22(Suppl. 1), S73-S78. doi: 10.1111/j.1440-1746.2006.04658.x
83. Kisseleva, T., and Brenner, D. A. (2008a). Fibrogenesis of parenchymal organs. Proc. Am. Thorac. Soc. 5, 338-342. doi: 10.1513/pats.200711-168DR
84. Kisseleva, T., and Brenner, D. A. (2008b). Mechanisms of fibrogenesis. Exp. Biol. Med. (Maywood). 233, 109-122. doi: 10.3181/0707-MR-190
85. Kisseleva, T., and Brenner, D. A. (2011). Anti-fibrogenic strategies and the regression of fibrosis. Best Pract. Res. Clin. Gastroenterol. 25, 305-317. doi: 10.1016/j.bpg.2011.02.011
86. Kisseleva, T., and Brenner, D. A. (2012). The phenotypic fate and functional role for bone marrow-derived stem cells in liver fibrosis. J. Hepatol. 56, 965-972. doi: 10.1016/j.jhep.2011.09.021
87. Kisseleva, T., Cong, M., Paik, Y., Scholten, D., Jiang, C., Benner, C.,et al. (2012). Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis. Proc. Natl. Acad. Sci. U.S.A. 109, 9448-9453. doi: 10.1073/pnas.1201840109
88. Kisseleva, T., Uchinami, H., Feirt, N., Quintana-Bustamante, O., Segovia, J. C., Schwabe, R. F.,et al. (2006). Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J. Hepatol. 45, 429-438. doi: 10.1016/j.jhep.2006.04.014
89. Kisseleva, T., von Kockritz-Blickwede, M., Reichart, D., McGillvray, S. M., Wingender, G., Kronenberg, M.,et al. (2011). Fibrocyte-like cells recruited to the spleen support innate and adaptive immune responses to acute injury or infection. J. Mol. Med. 89, 997-1013. doi: 10.1007/s00109-011-0756-0
90. Kleaveland, K. R., Moore, B. B., and Kim, K. K. (2014). Paracrine functions of fibrocytes to promote lung fibrosis. Expert. Rev. Respir. Med. 8, 163-172. doi: 10.1586/17476348.2014.862154
91. Knittel, T., Kobold, D., Saile, B., Grundmann, A., Neubauer, K., Piscaglia, F.,et al. (1999). Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential. Gastroenterology 117, 1205-1221. doi: 10.1016/S0016-5085(99)70407-5
92. Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C.,et al. (2008). Senescence of activated stellate cells limits liver fibrosis. Cell 134, 657-667. doi: 10.1016/j.cell.2008.06.049
93. Kruglov, E. A., Jain, D., and Dranoff, J. A. (2002). Isolation of primary rat liver fibroblasts. J. Investig. Med. 50, 179-184. doi: 10.2310/6650.2002.33431
94. Lemoinne, S., Cadoret, A., El Mourabit, H., Thabut, D., and Housset, C. (2013). Origins and functions of liver myofibroblasts. Biochim. Biophys. Acta 1832, 948-954. doi: 10.1016/j.bbadis.2013.02.019
95. Li, Z., Dranoff, J. A., Chan, E. P., Uemura, M., Sevigny, J., and Wells, R. G. (2007). Transforming growth factor-beta and substrate stiffness regulate portal fibroblast activation in culture. Hepatology 46, 1246-1256. doi: 10.1002/hep.21792
96. Lin, S. L., Kisseleva, T., Brenner, D. A., and Duffield, J. S. (2008). Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am. J. Pathol. 173, 1617-1627. doi: 10.2353/ajpath.2008.080433
97. Liu, C., Gaca, M. D., Swenson, E. S., Vellucci, V. F., Reiss, M., and Wells, R. G. (2003). Smads 2 and 3 are differentially activated by transforming growth factor-beta (TGF-beta) in quiescent and activated hepatic stellate cells. Constitutive nuclear localization of Smads in activated cells is TGF-beta-independent. J. Biol. Chem. 278, 11721-11728. doi: 10.1074/jbc.M207728200
98. Liu, X., Xu, J., Brenner, D. A., and Kisseleva, T. (2013). Reversibility of Liver Fibrosis and Inactivation of Fibrogenic Myofibroblasts. Curr. Pathobiol. Rep. 1, 209-214. doi: 10.1007/s40139-013-0018-7
99. Lujambio, A., Akkari, L., Simon, J., Grace, D., Tschaharganeh, D. F., Bolden, J. E.,et al. (2013). Non-cell-autonomous tumor suppression by p53. Cell 153, 449-460. doi: 10.1016/j.cell.2013.03.020
100. Magness, S. T., and Brenner, D. A. (1999). Targeted disruption of the mouse ferrochelatase gene producing an exon 10 deletion. Biochim. Biophys. Acta 1453, 161-174. doi: 10.1016/S0925-4439(98)00096-9
101. Magness, S. T., Bataller, R., Yang, L., and Brenner, D. A. (2004). A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations. Hepatology 40, 1151-1159. doi: 10.1002/hep.20427
102. Mair, M., Zollner, G., Schneller, D., Musteanu, M., Fickert, P., Gumhold, J.,et al. (2010). Signal transducer and activator of transcription 3 protects from liver injury and fibrosis in a mouse model of sclerosing cholangitis. Gastroenterology 138, 2499-2508. doi: 10.1053/j.gastro.2010.02.049
103. Mann, J., Chu, D. C., Maxwell, A., Oakley, F., Zhu, N. L., Tsukamoto, H.,et al. (2010). MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis. Gastroenterology 138, 705-714, 714 e1-e4.
104. Mann, J., and Mann, D. A. (2009). Transcriptional regulation of hepatic stellate cells. Adv. Drug. Deliv. Rev. 61, 497-512. doi: 10.1016/j.addr.2009.03.011
105. McHedlidze, T., Waldner, M., Zopf, S., Walker, J., Rankin, A. L., Schuchmann, M.,et al. (2013). Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis. Immunity 39, 357-371. doi: 10.1016/j.immuni.2013.07.018
106. Mederacke, I., Hsu, C. C., Troeger, J. S., Huebener, P., Mu, X., Dapito, D. H.,et al. (2013). Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat. Commun. 4, 2823. doi: 10.1038/ncomms3823
107. Meng, F., Wang, K., Aoyama, T., Grivennikov, S. I., Paik, Y., Scholten, D.,et al. (2012). Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. Gastroenterology 143, 765-76 e1-3.
108. Meurer, S. K., Alsamman, M., Sahin, H., Wasmuth, H. E., Kisseleva, T., Brenner, D. A.,et al. (2013). Overexpression of endoglin modulates TGF-beta1-signalling pathways in a novel immortalized mouse hepatic stellate cell line. PLoS ONE 8:e56116. doi: 10.1371/journal.pone.0056116
109. Michalopoulos, G. K. (2007). Liver regeneration. J. Cell Physiol. 213, 286-300. doi: 10.1002/jcp.21172
110. Moore, B. B., Kolodsick, J. E., Thannickal, V. J., Cooke, K., Moore, T. A., Hogaboam, C.,et al. (2005). CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am. J. Pathol. 166, 675-684. doi: 10.1016/S0002-9440(10)62289-4
111. Moore, B. B., Murray, L., Das, A., Wilke, C. A., Herrygers, A. B., and Toews, G. B. (2006). The role of CCL12 in the recruitment of fibrocytes and lung fibrosis. Am. J. Respir. Cell Mol. Biol. 35, 175-181. doi: 10.1165/rcmb.2005-0239OC
112. Muhanna, N., Doron, S., Wald, O., Horani, A., Eid, A., Pappo, O.,et al. (2008). Activation of hepatic stellate cells after phagocytosis of lymphocytes: a novel pathway of fibrogenesis. Hepatology 48, 963-977. doi: 10.1002/hep.22413
113. Niedermeier, M., Reich, B., Gomez, M. R., Denzel, A., Schmidbauer, K., Gobel, N.,et al. (2009). CD4+ T cells control the differentiation of Gr1+ monocytes into fibrocytes. Proc. Natl. Acad. Sci. U.S.A. 106, 17892-17897. doi: 10.1073/pnas.0906070106
114. Österreicher, C. H., Penz-Österreicher, M., Grivennikov, S. I., Guma, M., Koltsova, E. K., Datz, C.,et al. (2011). Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver. Proc. Natl. Acad. Sci. U.S.A. 108, 308-313. doi: 10.1073/pnas.1017547108
115. Park, P. J. (2009). ChIP-seq: advantages and challenges of a maturing technology. Nat. Rev. Genet. 10, 669-680. doi: 10.1038/nrg2641
116. Parola, M., Marra, F., and Pinzani, M. (2008). Myofibroblast - like cells and liver fibrogenesis: emerging concepts in a rapidly moving scenario. Mol. Aspects Med. 29, 58-66. doi: 10.1016/j.mam.2007.09.002
117. Parsons, C. J., Stefanovic, B., Seki, E., Aoyama, T., Latour, A. M., Marzluff, W. F.,et al. (2011). Mutation of the 5'-untranslated region stem-loop structure inhibits alpha1(I). collagen expression in vivo. J. Biol. Chem. 286, 8609-8619. doi: 10.1074/jbc.M110.189118
118. Pepke, S., Wold, B., and Mortazavi, A. (2009). Computation for ChIP-seq and RNA-seq studies. Nat. Methods 6, S22-S32. doi: 10.1038/nmeth.1371
119. Phillips, R. J., Burdick, M. D., Hong, K., Lutz, M. A., Murray, L. A., Xue, Y. Y.,et al. (2004). Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J. Clin. Invest. 114, 438-446. doi: 10.1172/JCI200420997
120. Pilling, D., Fan, T., Huang, D., Kaul, B., and Gomer, R. H. (2009). Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts. PLoS ONE 4:e7475. doi: 10.1371/journal.pone.0007475
121. Pinzani, M., and Marra, F. (2001). Cytokine receptors and signaling in hepatic stellate cells. Semin. Liver Dis. 21, 397-416. doi: 10.1055/s-2001-17554
122. Pope, S. M., Fulkerson, P. C., Blanchard, C., Akei, H. S., Nikolaidis, N. M., Zimmermann, N.,et al. (2005). Identification of a cooperative mechanism involving interleukin-13 and eotaxin-2 in experimental allergic lung inflammation. J. Biol. Chem. 280, 13952-13961. doi: 10.1074/jbc.M406037200
123. Quan, T. E., and Bucala, R. (2007). Culture and analysis of circulating fibrocytes. Methods Mol. Med. 135, 423-434. doi: 10.1007/978-1-59745-401-8_28
124. Quan, T. E., Cowper, S., Wu, S. P., Bockenstedt, L. K., and Bucala, R. (2004). Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int. J. Biochem. Cell Biol. 36, 598-606. doi: 10.1016/j.biocel.2003.10.005
125. Reif, S., Lang, A., Lindquist, J. N., Yata, Y., Gabele, E., Scanga, A.,et al. (2003). The role of focal adhesion kinase-phosphatidylinositol 3-kinase-akt signaling in hepatic stellate cell proliferation and type I collagen expression. J. Biol. Chem. 278, 8083-8090. doi: 10.1074/jbc.M212927200
126. Reilkoff, R. A., Bucala, R., and Herzog, E. L. (2011). Fibrocytes: emerging effector cells in chronic inflammation. Nat. Rev. Immunol. 11, 427-435. doi: 10.1038/nri2990
127. Rinkevich, Y., Mori, T., Sahoo, D., Xu, P. X., Bermingham, J. R. Jr., and Weissman, I. L. (2012). Identification and prospective isolation of a mesothelial precursor lineage giving rise to smooth muscle cells and fibroblasts for mammalian internal organs, and their vasculature. Nat. Cell Biol. 14, 1251-1260. doi: 10.1038/ncb2610
128. Roderfeld, M., Rath, T., Voswinckel, R., Dierkes, C., Dietrich, H., Zahner, D.,et al. (2009). Bone marrow transplantation demonstrates medullar origin of CD34(+). fibrocytes and ameliorates hepatic fibrosis in Abcb4(-/-). mice. Hepatology 51, 267-276. doi: 10.1002/hep.23274
129. Russo, F. P., Alison, M. R., Bigger, B. W., Amofah, E., Florou, A., Amin, F.,et al. (2006). The bone marrow functionally contributes to liver fibrosis. Gastroenterology 130, 1807-1821. doi: 10.1053/j.gastro.2006.01.036
130. Sahebally, S. M., Burke, J. P., Chang, K. H., Kiernan, M. G., O'Connell, P. R., and Coffey, J. C. (2013). Circulating fibrocytes and Crohn's disease. Br. J. Surg. 100, 1549-1556. doi: 10.1002/bjs.9302
131. Sakai, N., Wada, T., Yokoyama, H., Lipp, M., Ueha, S., Matsushima, K.,et al. (2006). Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis. Proc. Natl. Acad. Sci. U.S.A. 103, 14098-14103. doi: 10.1073/pnas.0511200103
132. Scholten, D., Osterreicher, C. H., Scholten, A., Iwaisako, K., Gu, G., Brenner, D. A.,et al. (2010). Genetic labeling does not detect epithelial-to-mesenchymal transition of cholangiocytes in liver fibrosis in mice. Gastroenterology 139, 987-998. doi: 10.1053/j.gastro.2010.05.005
133. Scholten, D., Reichart, D., Paik, Y. H., Lindert, J., Bhattacharya, J., Glass, C. K.,et al. (2011). Migration of fibrocytes in fibrogenic liver injury. Am. J. Pathol. 179, 189-198. doi: 10.1016/j.ajpath.2011.03.049
134. Seki, E., De Minicis, S., Gwak, G. Y., Kluwe, J., Inokuchi, S., Bursill, C. A.,et al. (2009a). CCR1 and CCR5 promote hepatic fibrosis in mice. J. Clin. Invest. 119, 1858-1870.
135. Seki, E., De Minicis, S., Inokuchi, S., Taura, K., Miyai, K., van Rooijen, N.,et al. (2009b). CCR2 promotes hepatic fibrosis in mice. Hepatology 50, 185-197. doi: 10.1002/hep.22952
136. Seki, E., De Minicis, S., Osterreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A.,et al. (2007). TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat. Med. 13, 1324-1332. doi: 10.1038/nm1663
137. She, H., Xiong, S., Hazra, S., and Tsukamoto, H. (2005). Adipogenic transcriptional regulation of hepatic stellate cells. J. Biol. Chem. 280, 4959-4967. doi: 10.1074/jbc.M410078200
138. Shimamura, T., Fujisawa, T., Husain, S. R., Kioi, M., Nakajima, A., and Puri, R. K. (2008). Novel role of IL-13 in fibrosis induced by nonalcoholic steatohepatitis and its amelioration by IL-13R-directed cytotoxin in a rat model. J. Immunol. 181, 4656-4665. doi: 10.4049/jimmunol.181.7.4656
139. Stefanovic, B., and Brenner, D. A. (2003). 5' stem-loop of collagen alpha 1(I). mRNA inhibits translation in vitro but is required for triple helical collagen synthesis in vivo. J. Biol. Chem. 278, 927-933. doi: 10.1074/jbc.M209175200
140. Stefanovic, B., Hellerbrand, C., Holcik, M., Briendl, M., Aliebhaber, S., and Brenner, D. A. (1997). Posttranscriptional regulation of collagen alpha1(I). mRNA in hepatic stellate cells. Mol. Cell. Biol. 17, 5201-5209.
141. Stefanovic, B., Lindquist, J., and Brenner, D. A. (2000). The 5' stem-loop regulates expression of collagen alpha1(I). mRNA in mouse fibroblasts cultured in a three-dimensional matrix. Nucleic Acids Res. 28, 641-647. doi: 10.1093/nar/28.2.641
142. Stefanovic, B., Schnabl, B., and Brenner, D. A. (2002). Inhibition of collagen alpha 1(I). expression by the 5' stem-loop as a molecular decoy. J. Biol. Chem. 277, 18229-18237. doi: 10.1074/jbc.M108065200
143. Stefanovic, L., Brenner, D. A., and Stefanovic, B. (2005). Direct hepatotoxic effect of KC chemokine in the liver without infiltration of neutrophils. Exp. Biol. Med. (Maywood). 230, 573-586.
144. Strieter, R. M., Gomperts, B. N., and Keane, M. P. (2007). The role of CXC chemokines in pulmonary fibrosis. J. Clin. Invest. 117, 549-556. doi: 10.1172/JCI30562
145. Strieter, R. M., Keeley, E. C., Hughes, M. A., Burdick, M. D., and Mehrad, B. (2009). The role of circulating mesenchymal progenitor cells (fibrocytes). in the pathogenesis of pulmonary fibrosis. J. Leukoc. Biol. 86, 1111-1118. doi: 10.1189/jlb.0309132
146. Suzuki, K., Tanaka, M., Watanabe, N., Saito, S., Nonaka, H., and Miyajima, A. (2008). p75 Neurotrophin receptor is a marker for precursors of stellate cells and portal fibroblasts in mouse fetal liver. Gastroenterology 135, 270-281 e3. doi: 10.1053/j.gastro.2008.03.075
147. Taura, K., De Minicis, S., Seki, E., Hatano, E., Iwaisako, K., Osterreicher, C. H.,et al. (2008). Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis. Gastroenterology 135, 1729-1738. doi: 10.1053/j.gastro.2008.07.065
148. Taura, K., Miura, K., Iwaisako, K., Osterreicher, C. H., Kodama, Y., Penz-Osterreicher, M.,et al. (2010). Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice. Hepatology 51, 1027-1036. doi: 10.1002/hep.23368
149. Troeger, J. S., Mederacke, I., Gwak, G. Y., Dapito, D. H., Mu, X., Hsu, C. C.,et al. (2012). Deactivation of hepatic stellate cells during liver fibrosis resolution in mice. Gastroenterology 143, 1073-1083.e22. doi: 10.1053/j.gastro.2012.06.03
150. Tsukamoto, H. (2005a). Adipogenic phenotype of hepatic stellate cells. Alcohol. Clin. Exp. Res. 29, 132S-133S. doi: 10.1097/01.alc.0000189279.92602.f0
151. Tsukamoto, H. (2005b). Fat paradox in liver disease. Keio J. Med. 54, 190-192. doi: 10.2302/kjm.54.190
152. Tsukamoto, H., Zhu, N. L., Asahina, K., Mann, D. A., and Mann, J. (2011). Epigenetic cell fate regulation of hepatic stellate cells. Hepatol. Res. 41, 675-682. doi: 10.1111/j.1872-034X.2011.00804.x
153. Tsukamoto, H., Zhu, N. L., Wang, J., Asahina, K., and Machida, K. (2012). Morphogens and hepatic stellate cell fate regulation in chronic liver disease. J. Gastroenterol. Hepatol. 27(Suppl. 2), 94-98. doi: 10.1111/j.1440-1746.2011.07022.x
154. Tuchweber, B., Desmouliere, A., Bochaton-Piallat, M. L., Rubbia-Brandt, L., and Gabbiani, G. (1996). Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat. Lab. Invest. 74, 265-278.
155. Uchinami, H., Seki, E., Brenner, D. A., and D'Armiento, J. (2006). Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis. Hepatology 44, 420-429. doi: 10.1002/hep.21268
156. Uchio, K., Tuchweber, B., Manabe, N., Gabbiani, G., Rosenbaum, J., and Desmouliére, A. (2002). Cellular retinol-binding protein-1 expression and modulation during in vivo and in vitro myofibroblastic differentiation of rat hepatic stellate cells and portal fibroblasts. Lab. Invest. 82, 619-628. doi: 10.1038/labinvest.3780456
157. Venkataraman, G., Raman, R., Sasisekharan, V., and Sasisekharan, R. (1999). Molecular characteristics of fibroblast growth factor-fibroblast growth factor receptor-heparin-like glycosaminoglycan complex. Proc. Natl. Acad. Sci. U.S.A. 96, 3658-3663. doi: 10.1073/pnas.96.7.3658
158. von Kockritz-Blickwede, M., Goldmann, O., Thulin, P., Heinemann, K., Norrby-Teglund, A., Rohde, M.,et al. (2008). Phagocytosis-independent antimicrobial activity of mast cells by means of extracellular trap formation. Blood 111, 3070-3080. doi: 10.1182/blood-2007-07-104018
159. Wada, T., Sakai, N., Matsushima, K., and Kaneko, S. (2007). Fibrocytes: a new insight into kidney fibrosis. Kidney Int. 72, 269-273. doi: 10.1038/sj.ki.5002325
160. Watsky, M. A., Weber, K. T., Sun, Y., and Postlethwaite, A. (2010). New insights into the mechanism of fibroblast to myofibroblast transformation and associated pathologies. Int. Rev. Cell. Mol. Biol. 282, 165-192. doi: 10.1016/S1937-6448(10)82004-0
161. Wells, R. G. (2008). The role of matrix stiffness in regulating cell behavior. Hepatology 47, 1394-400. doi: 10.1002/hep.22193
162. Wells, R. G. (2014). The portal fibroblast: not just a poor man's stellate cell. Gastroenterology 147, 41-47. doi: 10.1053/j.gastro.2014.05.001
163. Wells, R. G., Kruglov, E., and Dranoff, J. A. (2004). Autocrine release of TGF-beta by portal fibroblasts regulates cell growth. FEBS Lett. 559, 107-110. doi: 10.1016/S0014-5793(04)00037-7
164. Wen, J. W., Olsen, A. L., Perepelyuk, M., and Wells, R. G. (2012). Isolation of rat portal fibroblasts by in situ liver perfusion. J. Vis. Exp. 64, 3669.
165. Yang, L., Jung, Y., Omenetti, A., Witek, R. P., Choi, S., Vandongen, H. M.,et al. (2008). Fate-mapping evidence that hepatic stellate cells are epithelial progenitors in adult mouse livers. Stem Cells 26, 2104-2113. doi: 10.1634/stemcells.2008-0115
166. Yang, M. D., Chiang, Y. M., Higashiyama, R., Asahina, K., Mann, D. A., Mann, J.,et al. (2012). Rosmarinic acid and baicalin epigenetically derepress peroxisomal proliferator-activated receptor gamma in hepatic stellate cells for their antifibrotic effect. Hepatology 55, 1271-1281. doi: 10.1002/hep.24792
167. Yata, Y., Scanga, A., Gillan, A., Yang, L., Reif, S., Breindl, M.,et al. (2003). DNase I-hypersensitive sites enhance alpha1(I). collagen gene expression in hepatic stellate cells. Hepatology 37, 267-76. doi: 10.1053/jhep.2003.50067
168. Yousefi, S., Gold, J. A., Andina, N., Lee, J. J., Kelly, A. M., Kozlowski, E.,et al. (2008). Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat. Med. 14, 949-953. doi: 10.1038/nm.1855
169. Yovchev, M. I., Zhang, J., Neufeld, D. S., Grozdanov, P. N., and Dabeva, M. D. (2009). Thymus cell antigen-1-expressing cells in the oval cell compartment. Hepatology 50, 601-611. doi: 10.1002/hep.23012